MF
PDLI

Magnetar Financial’s PDL BioPharma, Inc. PDLI Stock Holding History

Magnetar Financial’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-44,151
Closed -$128K – 786
2020
Q2 		$128K Buy
+44,151
New +$140K ﹤0.01% 411
2019
Q3 		– Sell
-325,833
Closed -$1.02M – 633
2019
Q2 		$1.02M Buy
325,833
+39,545
+14% +$128K 0.02% 169
2019
Q1 		$1.06M Buy
286,288
+185,599
+184% +$627K 0.03% 137
2018
Q4 		$292K Buy
+100,689
New +$277K 0.01% 191
2016
Q2 		– Sell
-112,375
Closed -$374K – 561
2016
Q1 		$374K Sell
112,375
-2,646
-2% -$8.25K 0.01% 259
2015
Q4 		$407K Buy
+115,021
New +$481K ﹤0.01% 213

Other funds holding PDLI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return